Eisai Company, Ltd. (ESALY.PK) In-licenses Anti-hepatitis B Agent Clevudine From Bukwang Pharm. Ind. Co., Ltd. (South Korea)
10/19/2005 5:12:13 PM
Eisai Co., Ltd. (TSE: 4523) announced today that the Company has in-licensed an anti-hepatitis B agent (generic name: clevudine) from Bukwang Pharm (Headquarters, Seoul, South Korea, President: Sung-Koo Lee).
comments powered by